SRK Capital reports a 46.94% gain in H1 2025, driven by standout portfolio execution. Learn how strategic moves and cash ...

SRK Capital highlights ImmuCell’s margin expansion, new product growth, and Re-Tain’s FDA potential. Discover why ICCC may be ...

The WNBA free agency pool is probably the deepest its ever been thanks to the impending CBA deal, meaning big names could be ...